Diagnostics

The healthcare industry is constantly striving for reduced costs while maintaining or enhancing patient well-being. The movement towards point-of-care diagnostics meets many of these requirements; however the diagnostic test and instrumentation must be reliable with a high degree of ease-of-use for healthcare professionals.

Sionex believes some of the work currently being undertaken from the human genome project and basic genomic and proteomic research relating to the early diagnosis of asymptomatic disease has tremendous benefits. Sionex's microDMx™ technology can play an important role in enabling this paradigm shift to occur by providing easy to use technology with high degrees of sensitivity and selectivity at reduced costs.

Sionex is engaged in discussions with leading life science companies concerning the utilization of microDMx™ technology in this marketplace.

Protection by Detection™

...microDMx™ technology can help protect the world's population from ravages of disease by potential of earlier diagnosis

To obtain a copy of Sionex's whitepapers please register here.